Collaborative Practice Agreement · PharmD
California Collaborative Practice Agreement for Pharmacists
Required. The Collaborative Practice Agreement is the written instrument California law names for a Pharmacist working with a physician. Below: the board that governs it, what it must contain, and the terms it has to carry.
Two distinct, real pathways, neither requiring an individual supervising physician the way APRN/PA models do: APh recognition (recently renamed toward 'Advanced Pharmacist Practitioner' by AB 1503, eff. 1/1/2026) grants broad clinical authority; separate §4052.xx statutes let ANY pharmacist furnish specific drugs under board-level (not per-physician) protocols.
Independent practice requires: Advanced Practice Pharmacist (APh) recognition (Bus. & Prof. Code §4210): 2 of 3 criteria — board-recognized specialty certification, an accredited postgraduate residency (≥50% direct patient care), or ≥1 year of clinical services under a collaborative practice agreement — unlocks broader §4052.6 scope (assessments, ordering/interpreting tests, initiating/adjusting/discontinuing drug therapy); OR statutory furnishing authority (Bus. & Prof. Code §4052 and numbered subsections) available to ANY licensed pharmacist under a STATEWIDE protocol jointly developed by the Board of Pharmacy and Medical Board — not an individual physician relationship — covering naloxone (§4052.01), PrEP (§4052.02), PEP (§4052.03), hormonal contraceptives (§4052.3), and other enumerated categories (travel medications, immunizations, smoking-cessation products, epinephrine).
What a California Collaborative Practice Agreement must contain
Governed by the California State Board of Pharmacy. Each numbered item is a statutory requirement the agreement must satisfy.
The Pharmacist may initiate, adjust, or discontinue drug therapy for a patient under a collaborative practice agreement with the Physician, as authorized under Business and Professions Code § 4052. No California State Board of Pharmacy pre-approval or advance filing of the collaborative practice agreement is required; the Pharmacist shall keep the agreement on file at the practice location.
Source: Cal. Bus. & Prof. Code § 4052
- The Collaborative Practice Agreement on file also carries 2 scope, 1 education, 1 registration, 1 authority clauses, generated in the document itself.
Statutes and rules cited
- Cal. Bus. & Prof. Code § 4052statute
Authorizes a pharmacist, under a collaborative practice agreement with a health care provider with prescriptive authority (or under a prescriber's written order/authorization consistent with entity policy), to initiate, adjust, or discontinue drug therapy for a patient, subject to notification and other conditions.
Terms it has to carry
Ratio, proximity, chart review, meeting and prescribing terms the agreement has to carry, from the state's supervision rules.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Separate prescribing terms required · controlled substances permitted
Personal DEA registration required for controlled-substance-related furnishing (§4052(b), §4052.6). No blanket Schedule II prohibition was found, but §4052 explicitly preserves other statutory Schedule II prescription requirements elsewhere in law — not unrestricted, just not flatly banned either.
Written agreement
Required
A collaborative practice agreement is one of three QUALIFYING paths to APh recognition — CONFIRMED via direct fetch of §4210 not an ongoing operational requirement once recognized; the CPA year is framed as a backward-looking qualifying criterion for the 2-year-renewable recognition, and §4052.6 lists what a recognized APh may do going forward with no agreement-maintenance language. The §4052.xx furnishing statutes separately require a STATEWIDE, board-developed protocol rather than an individual collaborating-physician relationship — a genuinely different, lighter mechanism than the APRN/PA model.
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — No pharmacist-ownership requirement found — Bus. & Prof. Code §4110 governs pharmacy licensing without specifying owner licensure, and a pharmacy license may reportedly issue to 'an individual, a firm, association, partnership, corporation, limited liability company, state government agency, trust, or political subdivision.' §4113 makes the 'pharmacist-in-charge' (not necessarily an owner) responsible for compliance.
§4110/§4113 confirmed via direct fetch in a follow-up pass — no ownership-by-licensure-type restriction found in either section.
Legal sources for these rules (8)
- Bus. & Prof. Code §4210 — Advanced Practice Pharmacist recognition criteria, as amended by AB 1503 (2025)
- Bus. & Prof. Code §4052.6 — APh scope
- Bus. & Prof. Code §4052 — General pharmacist-furnishing umbrella statute
- Bus. & Prof. Code §4052.01 — Naloxone furnishing (confirmed via AB 1535 bill text)
- Bus. & Prof. Code §4052.02, §4052.03 — PrEP/PEP furnishing (confirmed via SB 159 bill text)
- Bus. & Prof. Code §4052.3 — Hormonal contraceptive furnishing (secondary-sourced, not independently fetched verbatim)
- Bus. & Prof. Code §4110, §4113 — Pharmacy licensing/pharmacist-in-charge, confirmed verbatim
- AB 1503 (2025-26) — APh terminology update, eff. 1/1/2026
About California's rules
California's NPs reach genuine full independence (AB 890/SB 1451, ~6 years total) and CNMs need zero physician involvement for definitionally 'low-risk' pregnancy care — no hours threshold. NPs/PAs may also majority-own their own practice corporations (Corp. Code §13401.5), cutting against the assumption that CA's strict, actively-enforced CPOM regime (2026 AG settlements against Carbon Health, Aspen Dental) blocks all non-physician ownership. CRNA is order-based, not supervision-based. Esthetician laser use is a flat criminal misdemeanor — no delegation pathway exists.
Other clinicians in California: see the state overview.